Sativex for Multiple sclerosis spasticity
Quick answer: Sativex is used for Multiple sclerosis spasticity as part of a cannabinoid (thc/cbd combination) treatment regimen. Oromucosal spray containing delta-9-tetrahydrocannabinol and cannabidiol acting on CB1 and CB2 cannabinoid receptors The specific dosing for Multiple sclerosis spasticity is determined by your prescriber based on individual factors.
Why is Sativex used for Multiple sclerosis spasticity?
Sativex belongs to the Cannabinoid (THC/CBD combination) class. Oromucosal spray containing delta-9-tetrahydrocannabinol and cannabidiol acting on CB1 and CB2 cannabinoid receptors This action makes it useful for treating or managing Multiple sclerosis spasticity in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Sativex is the right choice for a specific patient depends on the type and severity of Multiple sclerosis spasticity, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Multiple sclerosis spasticity
Common adult dosing range: Up to 12 sprays per day, titrated. The actual dose for Multiple sclerosis spasticity depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Sativex medicine page.
What to expect
Sativex treatment for Multiple sclerosis spasticity typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Multiple sclerosis spasticity
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Sativex is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Cannabinoid (THC/CBD combination) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Sativex
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Sativex full prescribing information · All Cannabinoid (THC/CBD combination) alternatives
Frequently asked questions
How effective is Sativex for Multiple sclerosis spasticity?
Effectiveness varies by individual response, dose, and severity. Sativex is one of several treatment options for Multiple sclerosis spasticity, supported by clinical evidence within the cannabinoid (thc/cbd combination) class. Discuss expected response with your prescriber.
How long do I need to take Sativex for Multiple sclerosis spasticity?
Treatment duration depends on the nature of Multiple sclerosis spasticity — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Sativex when used for Multiple sclerosis spasticity?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Sativex for Multiple sclerosis spasticity?
Yes. Multiple medicines and non-drug options exist for Multiple sclerosis spasticity. Alternatives within the cannabinoid (thc/cbd combination) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.